nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Assessment of the hepatitis B birth dose vaccination program, Papua New Guinea, 2014
|
Wiesen, Eric |
|
2016 |
34 |
3 |
p. 367-372 6 p. |
artikel |
2 |
Brucella suis strain 2 vaccine is safe and protective against heterologous Brucella spp. infections
|
Zhu, Liangquan |
|
2016 |
34 |
3 |
p. 395-400 6 p. |
artikel |
3 |
Completion and compliance of childhood vaccinations in the United States
|
Kurosky, Samantha K. |
|
2016 |
34 |
3 |
p. 387-394 8 p. |
artikel |
4 |
Cross-clade protective immune responses of NS1-truncated live attenuated H5N1 avian influenza vaccines
|
Shi, Shaohua |
|
2016 |
34 |
3 |
p. 350-357 8 p. |
artikel |
5 |
Development of a high-yield reassortant influenza vaccine virus derived from the A/Anhui/1/2013 (H7N9) strain
|
Nakamura, Kazuya |
|
2016 |
34 |
3 |
p. 328-333 6 p. |
artikel |
6 |
Editorial Board/Aims and Scope
|
|
|
2016 |
34 |
3 |
p. IFC- 1 p. |
artikel |
7 |
Effect of substituting IPV for tOPV on immunity to poliovirus in Bangladeshi infants: An open-label randomized controlled trial
|
Mychaleckyj, Josyf C. |
|
2016 |
34 |
3 |
p. 358-366 9 p. |
artikel |
8 |
Hepatitis E vaccine: WHO position paper, May 2015 – Recommendations
|
WHO, |
|
2016 |
34 |
3 |
p. 304-305 2 p. |
artikel |
9 |
How many OPV rounds are required to stop wild polio virus circulation in a developed country? Lessons from the Israeli experience
|
Tasher, Diana |
|
2016 |
34 |
3 |
p. 299-301 3 p. |
artikel |
10 |
Japanese Encephalitis Vaccines: WHO position paper, February 2015 – Recommendations
|
WHO, |
|
2016 |
34 |
3 |
p. 302-303 2 p. |
artikel |
11 |
National hospital data for intussusception: Data linkage and retrospective analysis to assess quality and use in vaccine safety surveillance
|
Samad, Lamiya |
|
2016 |
34 |
3 |
p. 373-379 7 p. |
artikel |
12 |
Optimization of physiological properties of hydroxyapatite as a vaccine adjuvant
|
Hayashi, Masayuki |
|
2016 |
34 |
3 |
p. 306-312 7 p. |
artikel |
13 |
Pertussis specific cell-mediated immune responses ten years after acellular pertussis booster vaccination in young adults
|
Gröndahl-Yli-Hannuksela, Kirsi |
|
2016 |
34 |
3 |
p. 341-349 9 p. |
artikel |
14 |
Prediction and identification of novel IBV S1 protein derived CTL epitopes in chicken
|
Tan, Lei |
|
2016 |
34 |
3 |
p. 380-386 7 p. |
artikel |
15 |
Retrospective economic evaluation of childhood 7-valent pneumococcal conjugate vaccination in Australia: Uncertain herd impact on pneumonia critical
|
Newall, A.T. |
|
2016 |
34 |
3 |
p. 320-327 8 p. |
artikel |
16 |
Risk and outcomes of invasive pneumococcal disease in adults with underlying conditions in the post-PCV7 era, The Netherlands
|
Wagenvoort, Gertjan H.J. |
|
2016 |
34 |
3 |
p. 334-340 7 p. |
artikel |
17 |
Safety and efficacy of a cytomegalovirus glycoprotein B (gB) vaccine in adolescent girls: A randomized clinical trial
|
Bernstein, David I. |
|
2016 |
34 |
3 |
p. 313-319 7 p. |
artikel |